tailieunhanh - Báo cáo y học: " Seropositivity of Hepatitis B virus and Hepatitis C virus dual Infection among blood donors in Nyala Teaching Hospital"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Seropositivity of Hepatitis B virus and Hepatitis C virus dual Infection among blood donors in Nyala Teaching Hospital | Virology Journal BioMed Central Open Access Short report Seropositivity of Hepatitis B virus and Hepatitis C virus dual Infection among blood donors in Nyala Teaching Hospital Mustafa Abdalla Ali Abou 1 2 and Yassir Mohammed Eltahir3 Address Department of Laboratories Administration State Ministry of Health South Dar Fur Nyala Sudan 2UNAMID Level 1 Clinic Nyala South Dar Fur Sudan and 3Department of Preventive Medicine Veterinary Public Health Faculty of Veterinary Science University of Nyala Nyala Sudan Email Mustafa Abdalla Ali Abou - mustafa_abou@ Yassir Mohammed Eltahir - yassirtahir@ Corresponding author Published 22 December 2009 Received 5 November 2009 _ n. jmvz Accepted 22 December 2009 Virology Journal 2009 6 227 doi 1743-422X-6-227 This article is available from http content 6 1 227 2009 Abou and Eltahir licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract The aim of this study was to determine the seropositivity of Hepatitis B virus HBV and Hepatitis C virus HCV dual infection among blood donors in Nyala Teaching Hospital which is the biggest 400 beds hospital in great Dar Fur of Western Sudan. 400 blood donors were tested serologically for the detection of HBsAg and anti-HCV antibodies. Only one out of the 400 examined blood donors was detected reactive for both HBsAg and anti-HCV antibodies. The study concluded that the seropositivity of HBV and HCV dual infection among population studied is uncommon. Introduction Dual infection with HBV and HCV leads to more aggressive liver disease 1 . In addition to chronic liver disease coinfection of HBV and HCV is frequently found in injection drug users IDU 2 patients on .